Compile Data Set for Download or QSAR
Report error Found 59 of affinity data for UniProtKB/TrEMBL: Q9P2J5
TargetLeucine--tRNA ligase, cytoplasmic(Human)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50241779(CHEMBL4082159)
Affinity DataEC50:  1.37E+5nMAssay Description:Inhibition of cytoplasmic LeuRS in human HepG2 cells assessed as reduction in protein synthesis preincubated for 48 hrs followed by L-[14C]leucine ad...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLeucine--tRNA ligase, cytoplasmic(Human)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50241781(CHEMBL4066833)
Affinity DataEC50:  3.95E+4nMAssay Description:Inhibition of cytoplasmic LeuRS in human HepG2 cells assessed as reduction in protein synthesis preincubated for 48 hrs followed by L-[14C]leucine ad...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLeucine--tRNA ligase, cytoplasmic(Human)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50241780(CHEMBL4105269)
Affinity DataEC50:  8.28E+4nMAssay Description:Inhibition of cytoplasmic LeuRS in human HepG2 cells assessed as reduction in protein synthesis preincubated for 48 hrs followed by L-[14C]leucine ad...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLeucine--tRNA ligase, cytoplasmic(Human)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50241782(CHEMBL4081207)
Affinity DataEC50:  1.16E+5nMAssay Description:Inhibition of cytoplasmic LeuRS in human HepG2 cells assessed as reduction in protein synthesis preincubated for 48 hrs followed by L-[14C]leucine ad...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLeucine--tRNA ligase, cytoplasmic(Human)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50241778(CHEMBL4086672)
Affinity DataEC50:  9.70E+4nMAssay Description:Inhibition of cytoplasmic LeuRS in human HepG2 cells assessed as reduction in protein synthesis preincubated for 48 hrs followed by L-[14C]leucine ad...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLeucine--tRNA ligase, cytoplasmic(Human)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50241757(CHEMBL4066786)
Affinity DataEC50:  1.05E+5nMAssay Description:Inhibition of cytoplasmic LeuRS in human HepG2 cells assessed as reduction in protein synthesis preincubated for 48 hrs followed by L-[14C]leucine ad...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLeucine--tRNA ligase, cytoplasmic(Human)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50241756(CHEMBL4075879)
Affinity DataEC50:  3.05E+4nMAssay Description:Inhibition of cytoplasmic LeuRS in human HepG2 cells assessed as reduction in protein synthesis preincubated for 48 hrs followed by L-[14C]leucine ad...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLeucine--tRNA ligase, cytoplasmic(Human)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50241754(CHEMBL4077894)
Affinity DataEC50:  1.96E+4nMAssay Description:Inhibition of cytoplasmic LeuRS in human HepG2 cells assessed as reduction in protein synthesis preincubated for 48 hrs followed by L-[14C]leucine ad...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLeucine--tRNA ligase, cytoplasmic(Human)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075067(((S)-2-Amino-4-methyl-pentanoyl)-sulfamic acid (2R...)
Affinity DataIC50: 1.60nMAssay Description:Compound tested for the inhibition of Escherichia coli Leucyl-tRNA synthetaseMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLeucine--tRNA ligase, cytoplasmic(Human)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075069(((S)-2-Amino-4-methyl-pentanoyl)-sulfamic acid (2R...)
Affinity DataIC50: 2nMAssay Description:Compound tested for the inhibition of Escherichia coli Leucyl-tRNA synthetaseMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLeucine--tRNA ligase, cytoplasmic(Human)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075055(((S)-2-Amino-4-methyl-pentanoyl)-sulfamic acid (2R...)
Affinity DataIC50: 6nMAssay Description:Compound tested for the inhibition of Escherichia coli Leucyl-tRNA synthetaseMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLeucine--tRNA ligase, cytoplasmic(Human)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50093005((4aR,6S,7R,7aS)-7-[2-((S)-2-Amino-4-methyl-pentano...)
Affinity DataIC50: 16nMAssay Description:Compound was evaluated for its inhibitory activity against Leucyl-tRNA synthetase from staphylococcus aureus WCUH29More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLeucine--tRNA ligase, cytoplasmic(Human)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50458119(Leusa)
Affinity DataIC50: 22nMAssay Description:Inhibition of catalytic activity of LRS (unknown origin) by aminoleucylation assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMedPDB3D3D Structure (crystal)
TargetLeucine--tRNA ligase, cytoplasmic(Human)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50286775(CHEMBL4174152)
Affinity DataIC50: 33nMAssay Description:Inhibition of human LeuRS assessed as reduction in ATP consumptionMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLeucine--tRNA ligase, cytoplasmic(Human)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50550346(CHEMBL4558130)
Affinity DataIC50: 70nMAssay Description:Inhibition of catalytic activity of LRS (unknown origin) by aminoleucylation assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLeucine--tRNA ligase, cytoplasmic(Human)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50286766(CHEMBL4163450)
Affinity DataIC50: 160nMAssay Description:Inhibition of human LeuRS assessed as reduction in ATP consumptionMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLeucine--tRNA ligase, cytoplasmic(Human)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50286768(CHEMBL4171458)
Affinity DataIC50: 220nMAssay Description:Inhibition of human LeuRS assessed as reduction in ATP consumptionMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLeucine--tRNA ligase, cytoplasmic(Human)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50550345(CHEMBL4104169)
Affinity DataIC50: 337nMAssay Description:Inhibition of catalytic activity of LRS (unknown origin) by aminoleucylation assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLeucine--tRNA ligase, cytoplasmic(Human)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50286767(CHEMBL4172643)
Affinity DataIC50: 490nMAssay Description:Inhibition of human LeuRS assessed as reduction in ATP consumptionMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLeucine--tRNA ligase, cytoplasmic(Human)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075067(((S)-2-Amino-4-methyl-pentanoyl)-sulfamic acid (2R...)
Affinity DataIC50: 600nMAssay Description:Compound tested for the inhibition of human Leucyl-tRNA synthetaseMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLeucine--tRNA ligase, cytoplasmic(Human)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075069(((S)-2-Amino-4-methyl-pentanoyl)-sulfamic acid (2R...)
Affinity DataIC50: 730nMAssay Description:Compound tested for the inhibition of human Leucyl-tRNA synthetaseMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLeucine--tRNA ligase, cytoplasmic(Human)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50286765(CHEMBL4159778)
Affinity DataIC50: 850nMAssay Description:Inhibition of human LeuRS assessed as reduction in ATP consumptionMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLeucine--tRNA ligase, cytoplasmic(Human)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075068(((2S,3S)-2-Amino-3-methyl-pentanoyl)-sulfamic acid...)
Affinity DataIC50: 1.00E+3nMAssay Description:Compound tested for the inhibition of Escherichia coli Leucyl-tRNA synthetaseMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLeucine--tRNA ligase, cytoplasmic(Human)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50286772(CHEMBL4160841)
Affinity DataIC50: 1.10E+3nMAssay Description:Inhibition of human LeuRS assessed as reduction in ATP consumptionMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLeucine--tRNA ligase, cytoplasmic(Human)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075055(((S)-2-Amino-4-methyl-pentanoyl)-sulfamic acid (2R...)
Affinity DataIC50: 1.15E+3nMAssay Description:Compound tested for the inhibition of human Leucyl-tRNA synthetaseMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLeucine--tRNA ligase, cytoplasmic(Human)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50286774(CHEMBL4163140)
Affinity DataIC50: 1.20E+3nMAssay Description:Inhibition of human LeuRS assessed as reduction in ATP consumptionMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLeucine--tRNA ligase, cytoplasmic(Human)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50111476(1-[5-(4''-Chloro-biphenyl-4-yloxy)-pentyl]-3-pyrid...)
Affinity DataIC50: 1.31E+3nMAssay Description:Inhibitory activity against Echovirus 9 using plaque reduction assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLeucine--tRNA ligase, cytoplasmic(Human)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50093003((4aR,6S,7R,7aS)-7-[2-((2S,3S)-2-Amino-3-methyl-pen...)
Affinity DataIC50: 1.55E+3nMAssay Description:Compound was evaluated for its inhibitory activity against Leucyl-tRNA synthetase from staphylococcus aureus WCUH29More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLeucine--tRNA ligase, cytoplasmic(Human)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50286771(CHEMBL4167692)
Affinity DataIC50: 2.00E+3nMAssay Description:Inhibition of human LeuRS assessed as reduction in ATP consumptionMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLeucine--tRNA ligase, cytoplasmic(Human)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50093001((4aR,6S,7R,7aS)-7-[2-((S)-2-Amino-3-methyl-butyryl...)
Affinity DataIC50: 2.30E+3nMAssay Description:Compound was evaluated for its inhibitory activity against Leucyl-tRNA synthetase from staphylococcus aureus WCUH29More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLeucine--tRNA ligase, cytoplasmic(Human)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50286770(CHEMBL4171058)
Affinity DataIC50: 3.40E+3nMAssay Description:Inhibition of human LeuRS assessed as reduction in ATP consumptionMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLeucine--tRNA ligase, cytoplasmic(Human)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50286769(CHEMBL4161986)
Affinity DataIC50: 3.90E+3nMAssay Description:Inhibition of human LeuRS assessed as reduction in ATP consumptionMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLeucine--tRNA ligase, cytoplasmic(Human)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50286773(CHEMBL4174897)
Affinity DataIC50: 4.50E+3nMAssay Description:Inhibition of human cytoplasmic LeuRS assessed as reduction in protein synthesis measured after 10 mins in presence of [3H]Leu by scintillation count...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLeucine--tRNA ligase, cytoplasmic(Human)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075064(((S)-2-Amino-3-methyl-butyryl)-sulfamic acid (2R,3...)
Affinity DataIC50: 1.40E+4nMAssay Description:Compound tested for the inhibition of Escherichia coli Leucyl-tRNA synthetaseMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLeucine--tRNA ligase, cytoplasmic(Human)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50145676(CHEMBL3764310)
Affinity DataIC50: 1.87E+4nMAssay Description:Inhibition of human leucyl-tRNA synthetase assessed as reduction of [14C]-L-leucine ligation to tRNA incubated for 5 mins by scintillation counting m...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLeucine--tRNA ligase, cytoplasmic(Human)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075068(((2S,3S)-2-Amino-3-methyl-pentanoyl)-sulfamic acid...)
Affinity DataIC50: 2.00E+4nMAssay Description:Compound tested for the inhibition of Staphylococcus aureus Leucyl-tRNA synthetaseMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLeucine--tRNA ligase, cytoplasmic(Human)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50171203(1-[(S)-5-(4'-Chloro-biphenyl-4-yloxy)-3-methyl-pen...)
Affinity DataIC50: 2.50E+4nMAssay Description:Inhibitory activity against Echovirus 9 using plaque reduction assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLeucine--tRNA ligase, cytoplasmic(Human)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50171204(1-[(R)-5-(4'-Chloro-biphenyl-4-yloxy)-3-methyl-pen...)
Affinity DataIC50: 2.50E+4nMAssay Description:Inhibitory activity against Echovirus 9 using plaque reduction assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLeucine--tRNA ligase, cytoplasmic(Human)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50268308(CHEMBL4061292)
Affinity DataIC50: 2.64E+4nMAssay Description:Inhibition of LRS-dependent mTORC1 activation in HEK293 cells assessed as reduction in leucine-induced mTORC1-mediated S6 Kinase phosphorylation pret...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLeucine--tRNA ligase, cytoplasmic(Human)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50145675(CHEMBL3764493)
Affinity DataIC50: 2.76E+4nMAssay Description:Inhibition of human leucyl-tRNA synthetase assessed as reduction of [14C]-L-leucine ligation to tRNA incubated for 5 mins by scintillation counting m...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLeucine--tRNA ligase, cytoplasmic(Human)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50241754(CHEMBL4077894)
Affinity DataIC50: 3.88E+4nMAssay Description:Inhibition of human N-terminal 6His-tagged cytoplasmic LeuRS expressed in Escherichia coli BL21(DE3) assessed as L-[14C]leucine incorporation in to E...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLeucine--tRNA ligase, cytoplasmic(Human)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50268307(CHEMBL4074495)
Affinity DataIC50: 4.49E+4nMAssay Description:Inhibition of LRS-dependent mTORC1 activation in HEK293 cells assessed as reduction in leucine-induced mTORC1-mediated S6 Kinase phosphorylation pret...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLeucine--tRNA ligase, cytoplasmic(Human)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50145677(CHEMBL3765025)
Affinity DataIC50: 4.58E+4nMAssay Description:Inhibition of human leucyl-tRNA synthetase assessed as reduction of [14C]-L-leucine ligation to tRNA incubated for 5 mins by scintillation counting m...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLeucine--tRNA ligase, cytoplasmic(Human)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50241756(CHEMBL4075879)
Affinity DataIC50: 6.69E+4nMAssay Description:Inhibition of human N-terminal 6His-tagged cytoplasmic LeuRS expressed in Escherichia coli BL21(DE3) assessed as L-[14C]leucine incorporation in to E...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLeucine--tRNA ligase, cytoplasmic(Human)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50241780(CHEMBL4105269)
Affinity DataIC50: 9.66E+4nMAssay Description:Inhibition of human N-terminal 6His-tagged cytoplasmic LeuRS expressed in Escherichia coli BL21(DE3) assessed as L-[14C]leucine incorporation in to E...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLeucine--tRNA ligase, cytoplasmic(Human)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075066(((S)-2-Amino-propionyl)-sulfamic acid (2R,3S,4R,5R...)
Affinity DataIC50: 1.00E+5nMAssay Description:Compound tested for the inhibition of Escherichia coli Leucyl-tRNA synthetaseMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLeucine--tRNA ligase, cytoplasmic(Human)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075057([(S)-2-Amino-3-(3H-imidazol-4-yl)-propionyl]-sulfa...)
Affinity DataIC50: 1.00E+5nMAssay Description:Compound tested for the inhibition of Escherichia coli Leucyl-tRNA synthetaseMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLeucine--tRNA ligase, cytoplasmic(Human)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50075060(((S)-2-Amino-3-phenyl-propionyl)-sulfamic acid (2R...)
Affinity DataIC50: 1.00E+5nMAssay Description:Compound tested for the inhibition of Escherichia coli Leucyl-tRNA synthetaseMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLeucine--tRNA ligase, cytoplasmic(Human)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50145678(CHEMBL3763921)
Affinity DataIC50: 1.16E+5nMAssay Description:Inhibition of human leucyl-tRNA synthetase assessed as reduction of [14C]-L-leucine ligation to tRNA incubated for 5 mins by scintillation counting m...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetLeucine--tRNA ligase, cytoplasmic(Human)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50145674(CHEMBL2436531)
Affinity DataIC50: 1.16E+5nMAssay Description:Inhibition of human leucyl-tRNA synthetase assessed as reduction of [14C]-L-leucine ligation to tRNA incubated for 5 mins by scintillation counting m...More data for this Ligand-Target Pair
In DepthDetails Article
PubMed
Displayed 1 to 50 (of 59 total ) | Next | Last >>
Jump to: